Health Care Technology
Company Overview of Y-Prime, Inc.
Y-Prime, Inc. develops clinical trial software products and services. Its products include YPrime IRT, a patient and IP management solution that provides access to patient data and information with smart analytics; YPrime Monitoring Visit Report that helps clinical research associates, organizations, and sponsors to monitor and report activities at clinical trial sites; YPrime BYOD-ready eCOA, an electronic clinical outcome assessment solution that provides patients with access to study-related questionnaires and lets them enter patient reported outcomes on their personal smartphone or tablet; and YPrime eCSF solution for forecasting and demand planning, coordinating packaging and labeling, ...
263 Great Valley Parkway
Malvern, PA 19355
Founded in 2006
Key Executives for Y-Prime, Inc.
Chief Executive Officer and Director
Executive Vice President and Director
Senior Vice President of Quality, Compliance, Talent Development, and Culture
Compensation as of Fiscal Year 2017.
Y-Prime, Inc. Key Developments
YPrime Simplifies Clinical Trial Endpoint Collection with New eCOA Technology
Apr 12 17
YPrime announced the release of its data-driven electronic clinical outcome assessment (eCOA) technology platform. Designed to capture endpoints from multiple modalities and streamline patient data collection in clinical trials, YPrime's eCOA technology supports sponsors, sites and patients while delivering consumer-friendly applications built on the best standards of user experience principles. YPrime's eCOA solutions offer data capture in virtually any clinical research setting, with features that promote user convenience, compliance and data integrity: Device management Inventory is managed through a centralized web portal. Device agnostic sync All Information is shared across independent devices. Automated DCF processing, Missing and incorrect data are reduced or prevented with automated edit checks; which also speeds time to completion. Mobile reporting, Sponsors can access reports and metrics anywhere through mobile devices. Single sign on Only one password is required for investigator site staff and sponsors to access data across multiple trials. Ad-hoc analytics, Trend analyses can be performed on any data point. Instrument library, Sponsors have the ability to retain an instrument library for future studies. Flexible technology, Device agnostic models allow for the potential use of sponsors' current device inventories.
YPrime Announces Expansion of Interactive Response Technology Services with Introduction of IRT+
Mar 29 17
YPrime announced the expansion of its interactive response technology (IRT) services with the introduction of IRT+. A cloud-based platform, IRT+ combines traditional IRT functionality of patient randomization and clinical supply management with advanced features and a suite of services to offer sponsors full control and real-time visibility into their clinical supply chain, patient interactions and site activities. Key IRT+ components include: System configurability that accommodates post-release changes and trial-specific needs; Pooled material management across multiple clinical studies and programs; Self-service portal supports real-time analytics and adhoc reporting; Clinical supplies forecasting and demand planning; Mobile app that provides study milestone updates, critical information and alerts; A range of solutions for early through late phase clinical trials; Patient and site engagement tools. A unified architecture with YPrime's eCOA platform allows multiple efficiency gains through reduced duplication of patient identifiers, patient demographics and site details. Centralized reporting eliminates the time and labor associated with consolidating and formatting reports from disparate systems.
Square 1 Bank Announces Credit Facility to YPrime
Jun 14 16
Square 1 Bank, a division of Pacific Western Bank, announced that it has provided a $5 million credit facility to new client YPrime. Proceeds from the facility will be used to provide working capital as the company continues to address critical needs in clinical research.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries